There are several agents that target specific enzymes in the metabolic pathways of breast cancer, including HK, PK, PDC, GLUTs and lactate, in addition to that targeting metabolism-related molecular pathways and genes in the tumor microenvironment. The gene discussed is PDC; the disease is breast carcinoma.